Bio-Sep Overview

  • Founded
  • 2007
Founded
  • Status
  • Private
  • Employees
  • 6
Employees
  • Latest Deal Type
  • Later Stage VC
  • Latest Deal Amount
  • $97.1K
Latest Deal Amount
  • Investors
  • 2

Bio-Sep General Information

Description

Developer of a medical technology intended to magnetically separate rare blood cells. The company's technology uses an ultrasonic enhanced organosolv process and non-toxic organic chemicals to develop bio-separation of lignocellulosic material for the production of energy products and platform chemicals, enabling medical industry to integrate the separation process as a front-end technology at low cost.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Primary Office
  • Clapton Revel, Wooburn Moor
  • Buckinghamshire HP10 0NP
  • England, United Kingdom

Bio-Sep Timeline

2017201820192020
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Bio-Sep Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Later Stage VC 30-Jun-2019 $97.1K 00.000 00.000 Completed Clinical Trials - Phase 2
5. Later Stage VC 30-Oct-2018 00000 00.000 00.000 Completed Generating Revenue
4. Later Stage VC 31-Mar-2016 00000 00.000 00.000 Completed Generating Revenue
3. Loan 09-Dec-2015 0000 00.00 Completed Pre-Clinical Trials
2. Later Stage VC 12-Feb-2014 $5.3M $5.5M Completed Pre-Clinical Trials
1. Angel (individual) 10-Dec-2012 $195K $195K 00000 Completed Pre-Clinical Trials
To view Bio-Sep’s complete valuation and funding history, request access »

Bio-Sep Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
A Ordinary 000 00.000000 000.00 000.00 00 000.00 0.000
Ordinary 00,000 00.000000 000.00 000.00 00 000.00 00.000
A Ordinary 0,000 00.000000 00.00 00.00 00 00.00 0.000
Ordinary 52,489 $1.267040 $6.34 $6.34 1x $6.34 5.15%
Ordinary 18,000 $1.267040 $3.8 $3.8 1x $3.8 7.02%
To view Bio-Sep’s complete cap table history, request access »

Bio-Sep Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of a medical technology intended to magnetically separate rare blood cells. The company's technology uses an u
Biotechnology
Buckinghamshire, United Kingdom
6 As of 2020
00.000
0.000 0000-00-00
0000000000 0 00.000

0000 000

Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo con
00000 000000000 000 00000
Redcar, United Kingdom
00 As of 0000
00.000
00000000000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Bio-Sep Competitors (1)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
0000 0000000 00000 Venture Capital-Backed Redcar, United Kingdom 00 00.000 00000000000
To view Bio-Sep’s complete competitors history, request access »

Bio-Sep Executive Team (1)

Name Title Board Seat Contact Info
Anthony McGarel-Groves Founder, Finance Director & Board Member
To view Bio-Sep’s complete executive team members history, request access »

Bio-Sep Board Members (6)

Name Representing Role Since
Anthony McGarel-Groves Bio-Sep Founder, Finance Director & Board Member 000 0000
David Dutton Bio-Sep Board Member 000 0000
Geoffrey Drage Self Board Member 000 0000
Kenneth Day Bio-Sep Board Member 000 0000
Malcolm Gates Bio-Sep Chairman 000 0000
You’re viewing 5 of 6 board members. Get the full list »

Bio-Sep Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Bio-Sep Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
BRM Group Venture Capital Minority 000 0000 000000 0
The FSE Group Venture Capital Minority 000 0000 000000 0
To view Bio-Sep’s complete investors history, request access »